ERCC1 and head and neck squamous cell carcinoma: Although a polymorphism in ERCC1 (C8092A) has been reported to affect the mRNA stability and alter the DNA reparation capability, no differences were detected in the ERCC1 sequence of HNSCC survivors and patients undergoing cisplatin therapy.